Our trusted team of thought leaders provides the latest insights and perspectives on important health industry and management consulting trends and topics.
A 40,000+ employee Academic Medical Center (AMC) with several hospital sites, dozens of ambulatory facilities...
In M&A, success hinges on managing the most valuable asset: people. This insight explores why a people-centric approach is crucial for post-deal su...
This structured approach guides Med Affairs leaders in executing micro-transformations to drive meaningful impact for your organization and patients.
Vynamic helped the client develop an innovation capability to run agile experiments and identify potential solutions.
Following an acquisition, a global biopharmaceutical company needed to consolidate disparate brands into a single portfolio.
In the midst of integrating one company from a prior deal, a mid-sized pharmaceutical organization made an additional acquisition.
Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity.
A high-impact DEI strategy requires an intentional approach that aligns organizational leaders around a singular vision.
Navigating changes in structure and responsibilities can present operational and cultural challenges for a team.
Enhancing the performance of omnichannel activities is now a priority for many life sciences companies.
Medical affairs plays a critical role in key activities for pharmaceutical companies. This includes evidence generation, evidence dissemination.
A global pharmaceutical company based in Europe needed to ensure robust and consistent product launch execution by Medical Affairs teams.